GlassScriptPhysician profile
Andrea Attenasio
NPI 1801451125
$10,136.35
in general payments reported to CMS, 2019-2025
12 companies · $7,126 in 2025
The $7,126 reported for 2025 was more than what 85% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $3,010 · 2025: $7,126.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,735 · Food and Beverage: $2,764 · Grant: $1,500 · Education: $137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,735.10 |
| Food and Beverage | $2,764.24 |
| Grant | $1,500.00 |
| Education | $137.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $3,528.45 | 2025 | |
| Medical Device Business Services, INC. | $2,501.45 | 2024-2025 | Na, Stratafix |
| Goode Surgical INC | $1,399.85 | 2024-2025 | |
| Stryker Corporation | $1,390.39 | 2024-2025 | Pro, T2 Alpha, Mako |
| Zimmer Biomet Holdings, INC. | $808.37 | 2025 | Rosa, Tapestry |
| Sanara Medtech INC. | $150.00 | 2025 | Celleraterx |
| Restor3d, INC. | $140.18 | 2024 | |
| Smith+Nephew, INC. | $120.83 | 2024 | Evos |
| Kerecis Limited | $50.17 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Acera Surgical, INC. | $18.03 | 2024 | Restrata Wound Matrix |
| Ethicon US, LLC | $17.65 | 2024 | Stratafix |
| Lifenet Health | $10.98 | 2024 | Allograft Vmis Delivery System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrea Attenasio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.